166 related articles for article (PubMed ID: 12449497)
1. Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol.
Tuk B; van Gool T; Danhof M
J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):235-50. PubMed ID: 12449497
[TBL] [Abstract][Full Text] [Related]
2. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.
Mandema JW; Kuck MT; Danhof M
J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic interaction between midazolam and a low dose of ethanol in vivo.
Hoyo-Vadillo C; Mandema JW; Danhof M
Life Sci; 1995; 57(4):325-33. PubMed ID: 7603305
[TBL] [Abstract][Full Text] [Related]
4. Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship.
Mandema JW; Kuck MT; Danhof M
Br J Pharmacol; 1992 Jan; 105(1):164-70. PubMed ID: 1350744
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic analysis of the interaction between tiagabine and midazolam with an allosteric model that incorporates signal transduction.
Jonker DM; Vermeij DA; Edelbroek PM; Voskuyl RA; Piotrovsky VK; Danhof M
Epilepsia; 2003 Mar; 44(3):329-38. PubMed ID: 12614388
[TBL] [Abstract][Full Text] [Related]
6. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
Mandema JW; Tukker E; Danhof M
J Pharmacol Exp Ther; 1992 Jan; 260(1):36-44. PubMed ID: 1309878
[TBL] [Abstract][Full Text] [Related]
7. Modelling of the pharmacodynamics and pharmacodynamic interactions of CNS active drugs.
Danhof M; Mandema JW
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):516-9. PubMed ID: 1490817
[TBL] [Abstract][Full Text] [Related]
8. Drug discrimination analysis of midazolam under a three-lever procedure. II: Differential effects of benzodiazepine receptor agonists.
Sannerud CA; Ator NA
J Pharmacol Exp Ther; 1995 Oct; 275(1):183-93. PubMed ID: 7562548
[TBL] [Abstract][Full Text] [Related]
9. Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats.
Cleton A; Mazee D; Voskuyl RA; Danhof M
Br J Pharmacol; 1999 May; 127(1):227-35. PubMed ID: 10369477
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-EEG effect relationship of midazolam in aging BN/BiRij rats.
Hovinga S; Stijnen AM; Langemeijer MW; Mandema JW; van Bezooijen CF; Danhof M
Br J Pharmacol; 1992 Sep; 107(1):171-7. PubMed ID: 1422570
[TBL] [Abstract][Full Text] [Related]
11. Mechanism-based pharmacokinetic/pharmacodynamic modeling of the electroencephalogram effects of GABAA receptor modulators: in vitro-in vivo correlations.
Visser SA; Wolters FL; Gubbens-Stibbe JM; Tukker E; Van Der Graaf PH; Peletier LA; Danhof M
J Pharmacol Exp Ther; 2003 Jan; 304(1):88-101. PubMed ID: 12490579
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.
Mandema JW; Tukker E; Danhof M
Br J Pharmacol; 1991 Mar; 102(3):663-8. PubMed ID: 1364836
[TBL] [Abstract][Full Text] [Related]
13. Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys.
Paronis CA; Bergman J
J Pharmacol Exp Ther; 1999 Sep; 290(3):1222-9. PubMed ID: 10454498
[TBL] [Abstract][Full Text] [Related]
14. Mechanism-based modeling of the pharmacodynamic interaction of alphaxalone and midazolam in rats.
Visser SA; Huntjens DR; van der Graaf PH; Peletier LA; Danhof M
J Pharmacol Exp Ther; 2003 Nov; 307(2):765-75. PubMed ID: 12975494
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity.
Mandema JW; Sansom LN; Dios-Vièitez MC; Hollander-Jansen M; Danhof M
J Pharmacol Exp Ther; 1991 Apr; 257(1):472-8. PubMed ID: 1850477
[TBL] [Abstract][Full Text] [Related]
16. Blockade of behavioral effects of bretazenil by flumazenil and ZK 93,426 in pigeons.
Witkin JM; Acri JB; Gleeson S; Barrett JE
Pharmacol Biochem Behav; 1997 Jan; 56(1):1-7. PubMed ID: 8981602
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus properties of ethanol in the rat: differential effects of selective and nonselective benzodiazepine receptor agonists.
Bienkowski P; Iwinska K; Stefanski R; Kostowski W
Pharmacol Biochem Behav; 1997 Dec; 58(4):969-73. PubMed ID: 9408202
[TBL] [Abstract][Full Text] [Related]
18. Adaptive changes in the pharmacodynamics of midazolam in different experimental models of epilepsy: kindling, cortical stimulation and genetic absence epilepsy.
Cleton A; Voskuyl RA; Danhof M
Br J Pharmacol; 1998 Oct; 125(4):615-20. PubMed ID: 9831893
[TBL] [Abstract][Full Text] [Related]
19. The role of the hippocampus and 5-HT/GABA interaction in the central effects of benzodiazepine receptor ligands.
Nazar M; Siemiatkowski M; Członkowska A; Sienkiewicz-Jarosz H; Płaźnik A
J Neural Transm (Vienna); 1999; 106(5-6):369-81. PubMed ID: 10443544
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent EEG effects of zolpidem provide evidence for GABA(A) receptor subtype selectivity in vivo.
Visser SA; Wolters FL; van der Graaf PH; Peletier LA; Danhof M
J Pharmacol Exp Ther; 2003 Mar; 304(3):1251-7. PubMed ID: 12604703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
